SBC SBC Medical Group Holdings Inc
Services-Offices & Clinics of Doctors of Medicine · Nasdaq · SEC CIK 1930313 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.7%
TTM net income YoY19.8%
TTM EPS YoY21.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin72.2%
Operating margin39.9%
Net margin27.3%
FCF margin52.6%
EBITDA margin41.1%
Returns
ROE19.4%
ROA13.9%
ROIC (approx.)37.5%
Asset turnover0.51x
Leverage & solvency
Liabilities / assets28.6%
Debt / equity0.12x
Current ratio3.67x
Interest coverage181.93x
Cash quality & payout
Operating cash flow / net income1.97x
Accruals ratio-13.5%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 |
|---|---|---|---|
| Income statement | |||
| Revenue | $173.61M | $205.42M | $193.54M |
| Cost of revenue | $46.32M | $49.37M | $56.24M |
| Gross profit | $127.28M | $156.05M | $137.30M |
| SG&A expense | $59.80M | $57.67M | $66.23M |
| Operating income | $67.49M | $70.30M | $70.66M |
| Interest expense | $148,238 | $28,300 | $45,292 |
| Pretax income | $82.07M | $73.46M | $73.58M |
| Income tax | $31.02M | $26.77M | $35.02M |
| Net income | $50.99M | $46.61M | $39.37M |
| EBITDA | $70.17M | $74.10M | $82.91M |
| EPS (basic) | 0.50 | 0.48 | 0.42 |
| EPS (diluted) | 0.50 | 0.48 | 0.42 |
| Weighted avg. shares (diluted) | 103.00M | 96.56M | 94.19M |
| Balance sheet | |||
| Cash & equivalents | $163.77M | $125.04M | $103.02M |
| Short-term investments | $319,193 | $0 | — |
| Inventory | $2.79M | $1.49M | $3.09M |
| Current assets | $231.22M | $184.45M | $165.91M |
| PP&E, net | $7.54M | $8.77M | $13.58M |
| Goodwill | $15.43M | $4.61M | $3.59M |
| Intangibles | $47.74M | $1.59M | $19.74M |
| Total assets | $380.45M | $266.08M | $258.81M |
| Current liabilities | $61.12M | $61.19M | $92.45M |
| Short-term debt | $228,210 | $262,095 | $329,155 |
| Long-term debt | $42.83M | $6.60M | — |
| Total debt | $43.06M | $6.86M | — |
| Total liabilities | $117.14M | $71.06M | $115.00M |
| Shareholders' equity | $248.28M | $195.11M | $142.16M |
| Net debt | -$120.71M | -$118.18M | — |
| Shares outstanding | 102.58M | 102.75M | 94.19M |
| Cash flow statement | |||
| Operating cash flow | $24.67M | $20.58M | $50.67M |
| Capital expenditure | $1.40M | $2.56M | $8.54M |
| Free cash flow | $23.27M | $18.02M | $42.13M |
| Investing cash flow | -$20.97M | -$10.10M | $1.79M |
| Financing cash flow | $38.29M | $22.97M | $6.14M |
| Depreciation & amortization | $2.68M | $3.80M | $12.25M |
| Stock-based compensation | $0 | $13.02M | — |
| Share buybacks | $5.00M | $0 | — |
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.